FAAST

DataHealth & WellbeingSoftware
FAAST offers real time aerodynamics for indoor cyclists. We create a realistic cycling experience, where you feel the air resistance on your stationary bike, in the same way as you experience air resistance in the real world. In a forward-leaning position, you encounter little wind resistance and move quickly, but you may experience less comfort. Sitting upright allows you to generate more power, in a comfortable position, but also exposes you to more wind resistance, resulting in slower speeds. FAAST's revolutionary technology helps professional and recreational cyclists to find their fastest yet most comfortable cycling position.

ImmuneSpec

Health & Wellbeing
ImmuneSpec provides a cutting-edge immunopeptidomics platform that enhances immunogenic peptide identification with unparalleled accuracy. Their MS-based technology helps life sciences, biotech companies, and CROs accelerate vaccine, personalized medicine, and immunotherapy development. By delivering deep, unbiased immunopeptidome analysis, they enable the discovery of novel targets, optimization of antigens, and detection of rare neoepitopes. They also assist in refining biotherapeutics by identifying immunogenic regions to improve safety and efficacy.

Mymmo

Health & WellbeingReal Estate & PropTechSoftware
Mymmo is a comprehensive Managed Mobility Services (MMS) provider, specializing in helping businesses optimize their mobile operations. They offer a range of solutions including mobile device management, security, logistics, and support, ensuring companies can efficiently manage their mobile fleet while focusing on their core business. By combining cutting-edge technology with expert support, Mymmo helps organizations improve productivity, reduce costs, and maintain security across their mobile infrastructure. Their goal is to simplify and streamline mobility management for businesses of all sizes.

Sightera Biosciences

AIDataHealth & Wellbeing
Sightera Biosciences, is a pre-clinical stage biotech spin-off from the University of Antwerp in collaboration with the Antwerp University Hospital. Sightera focuses on developing innovative small molecules for oncology and regenerative medicine by combining patient-relevant models with artificial intelligence.